News

Juniper Pharma Services and XenoGesis strengthen alliance in early drug development services

2 months ago

Nottingham, UK – Juniper Pharma Services and XenoGesis have extended their strategic alliance around their Enabling Technologies Rapid Screen through the addition of the gold standard PBPK modelling and simulation software, GastroPlusTM. This expanded partnership brings greater understanding of a compound’s potential exposure in both preclinical and clinical studies. Jointly they are already working in

Major Progress in Next Generation Medicines Initiative

4 months ago

Nottingham, UK – Juniper Pharma Services, a subsidiary of Juniper Pharmaceuticals, Inc. (Nasdaq: JNP), has reached a key milestone in its work with CrystecPharma and the Advanced Manufacturing Supply Chain Initiative (AMSCI) to create a new platform to accelerate drug development. The contract development and manufacturing organisation (CDMO) now has CrystecPharma’s supercritical fluid technology platform

Webinar – The Importance of Dose Prediction for Early Drug Development

6 months ago

Juniper Pharma Services will be presenting a webinar with Xenogesis: The Importance of Dose Prediction for Early Drug Development at 3.00pm (BST) on Thursday 6th July 2017. The webinar will examine how gaining a thorough understanding of the chemical and pharmacological attributes of a drug substance through preclinical studies is paramount for providing an effective dosage form

Juniper Pharma Services Brings PSD-1 Spray Dryer Online

6 months ago

Nottingham, UK – Juniper Pharma Services (“the company” or “Juniper”), a subsidiary of Juniper Pharmaceuticals, Inc. (Nasdaq: JNP), has broadened its manufacturing capabilities bringing on-line its new spray dryer following the successful installation and validation of the advanced manufacturing equipment at its UK-based site. The contract development and manufacturing organisation (CDMO) has seen significant interest

Juniper Pharma Services expands granulation capabilities

1 year ago

Nottingham, UK – Juniper Pharma Services (“the company”), a subsidiary of Juniper Pharmaceuticals, Inc. (Nasdaq: JNP), has added a roller compactor to its enabling technologies platform to satisfy increasing market demand for its pharmaceutical development services. The UK-based contract development and manufacturing organisation (CDMO) has purchased a Gerteis MINI-PACTOR® to expand its granulation capabilities and

Webinar – An Integrated Bio-Pharmaceutics Approach For Effective Drug Development

1 year ago

Juniper Pharma Services will be presenting a webinar with Xenogesis: An Integrated Bio-Pharmaceutics Approach for Effective Drug Development at 3.00pm – 4.00pm (BST) on Thursday 8th September 2016. The webinar will examine why new drug candidates fail during development for many reasons, and will be centred around: Undesirable absorption and/or metabolism of the compound in man

Tablet press investment at Juniper Pharma Services

1 year ago

Nottingham, UK – Juniper Pharma Services (“the company”), a subsidiary of Juniper Pharmaceuticals, Inc. (Nasdaq: JNP), has bolstered its tablet manufacturing capabilities following the purchase and validation of an additional tablet press. The investment by the UK-based contract development and manufacturing organisation (CDMO) significantly extends its tablet production capacity and further strengthens the company’s ability

Juniper Pharma Services strengthens topicals capability

2 years ago

Nottingham, UK – Juniper Pharma Services (“the company”), a subsidiary of Juniper Pharmaceuticals, Inc. (Nasdaq: JNP), has reinforced its early stage topical and semi-solids capability by investing in a Becomix homogenizer mixer. The installation and validation of the new equipment extends the company’s ability to manufacture creams, ointments, and semi-solids to support clients’ clinical trial

Juniper Pharma Services scales up spray-drying capability

2 years ago

Nottingham, UK – Juniper Pharma Services (“the company”), a subsidiary of Juniper Pharmaceuticals, Inc. (Nasdaq: JNP), has reinforced its enabling technologies platform by making a substantial investment into its spray drying capabilities. The contract development and manufacturing organisation (CDMO) has placed an order for a PSD-1 spray dryer, which is manufactured by GEA Niro and